fluconazole and efinaconazole

fluconazole has been researched along with efinaconazole in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Bahn, YS; Cheong, E; Choi, JW; Jang, BK; Kim, D; Kim, HJ; Kim, S; Lee, DG; Lee, JS; Lee, KT; Lee, MH; Lee, YR; Park, JH; Park, KD; Park, SJ; Seo, KJ; Yeon, SK	1
Emami, S; Ghobadi, E; Saednia, S	1
Rosen, T; Stein Gold, LF	1
Lipner, SR; Scher, RK	1
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K	1

Reviews

2 review(s) available for fluconazole and efinaconazole

Article	Year
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development. European journal of medicinal chemistry, 2022, Mar-05, Volume: 231 Topics: Antifungal Agents; Drug Development; Fungi; Voriconazole	2022
Onychomycosis: Treatment and prevention of recurrence. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles	2019

Article

Year

Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development.

European journal of medicinal chemistry, 2022, Mar-05, Volume: 231

Topics: Antifungal Agents; Drug Development; Fungi; Voriconazole

2022

Onychomycosis: Treatment and prevention of recurrence.

Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles

2019

Other Studies

3 other study(ies) available for fluconazole and efinaconazole

Article	Year
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection. Journal of medicinal chemistry, 2021, 11-11, Volume: 64, Issue:21 Topics: Animals; Antifungal Agents; Cell Wall; Drug Evaluation, Preclinical; Drug Synergism; Female; Fungi; Humans; Male; Mice; Microbial Sensitivity Tests; Mycoses; Rats, Sprague-Dawley	2021
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action. Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3 Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States	2016
In vitro antifungal activity of luliconazole against nondermatophytic moulds. Medical mycology, 2020, Jul-01, Volume: 58, Issue:5 Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole	2020